5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia
Status:
Terminated
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the safety and efficacy of Azacytidine in
fludarabine-resistant chronic lymphocytic leukemia (CLL), Richter's transformation, and
T-cell prolymphocytic leukemia (T-PLL).